menu
    • menu

    Company profile for Solid Biosciences

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Solid Biosciences is a life science company focused on developing transformative treatments to improve the lives of patients living with Duchenne muscular dystrophy (Duchenne). Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive – work to address the disease at its core by correcting the underlying mutation with our gene therapy candidate, SGT-001. Solid has been purpose-built t...
    Solid Biosciences is a life science company focused on developing transformative treatments to improve the lives of patients living with Duchenne muscular dystrophy (Duchenne). Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive – work to address the disease at its core by correcting the underlying mutation with our gene therapy candidate, SGT-001. Solid has been purpose-built to advance the best science and accelerate the discovery and development of treatments that may benefit all patients with this devastating disease. Learn more about how we were founded and what drives us every day.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Solid BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    141 Portland Street Fifth Floor Cambridge, MA 02139
    Telephone
    Telephone
    (617) 337-4680
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.solidbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/solid-biosciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/SolidBioDMD

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Solid Biosciences Awards Inducement Grants Nasdaq LR 5635(c)(4))
    Solid Biosciences Awards Inducement Grants Nasdaq LR 5635(c)(4))

    02 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/02/3247859/0/en/Solid-Biosciences-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    02 Mar 2026
    Share Share
    Solid Biosciences Reports Favorable FDA Type C Meeting Outcome
    Solid Biosciences Reports Favorable FDA Type C Meeting Outcome

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234485/0/en/Solid-Biosciences-Announces-Positive-Feedback-from-Type-C-Meeting-with-FDA-for-SGT-003-Gene-Therapy-for-Duchenne-Muscular-Dystrophy.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Solid Biosciences To Present At Guggenheim Biotech Summit 2026
    Solid Biosciences To Present At Guggenheim Biotech Summit 2026

    06 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/06/3233778/0/en/Solid-Biosciences-to-Present-at-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    06 Feb 2026
    Share Share
    Solid Bio Highlights 2026 Neuromuscular Pipeline For AAV-SLB101
    Solid Bio Highlights 2026 Neuromuscular Pipeline For AAV-SLB101

    13 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/13/3218264/0/en/Solid-Biosciences-Provides-2026-Outlook-Underscoring-Neuromuscular-and-Cardiac-Pipeline-Momentum-and-Expanded-Access-to-Next-Generation-Capsid-AAV-SLB101.html

    GLOBENEWSWIRE
    13 Jan 2026
    Share Share
    Solid Biosciences Gets FDA Orphan Status For SGT-212 Gene Therapy
    Solid Biosciences Gets FDA Orphan Status For SGT-212 Gene Therapy

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217367/0/en/Solid-Biosciences-Receives-FDA-Orphan-Drug-Designation-for-SGT-212-Dual-Route-Gene-Therapy-for-the-Treatment-of-Friedreich-s-Ataxia.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    Solid Biosciences Initiates Phase 1B FALCON Trial For SGT-212
    Solid Biosciences Initiates Phase 1B FALCON Trial For SGT-212

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3216871/0/en/Solid-Biosciences-Doses-First-Participant-in-First-in-Class-Phase-1b-FALCON-Trial-Evaluating-SGT-212-Dual-Route-Gene-Therapy-for-the-Treatment-of-Friedreich-s-Ataxia.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search